Showing results (121-130 of 301) with videos related to
Sort By:
Pageof 31
Thyroid : Official Journal of the American Thyroid Association|December 4, 2024
Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid CarcinomaSarah Hamidi, Sireesha Yedururi, Mimi I Hu, et al.The Oncologist|April 16, 2014
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancerRamona Dadu, Steven G Waguespack, Steven I Sherman, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 22, 2003
Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type IISteven G Waguespack, Daniel L Koller, Kenneth E White, et al.Journal of Surgical Oncology|August 19, 2024
Clinical course of atypical parathyroid neoplasm with soft tissue extensionHope A Feldman, Naifa L Busaidy, Andres Tame-Elorduy, et al.Pediatric Blood & Cancer|March 31, 2021
Tumor surveillance for children and adolescents with cancer predisposition syndromes: The psychosocial impact reported by adolescents and caregiversKalene van Engelen, Maru Barrera, Jonathan D Wasserman, et al.Cancers|April 3, 2021
Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid CancerCaitlin O Caperton, Lee Ann Jolly, Nicole Massoll, et al.Thyroid : Official Journal of the American Thyroid Association|October 7, 2014
BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancerGerald S Falchook, Michael Millward, David Hong, et al.Clinical Endocrinology|September 17, 2013
Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centreHassan Shawa, Khaled M Elsayes, Sanaz Javadi, et al.Surgery|January 3, 2014
Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing’s syndromeLilah F Morris, Rachel S Harris, Denái R Milton, et al.The Journal of Clinical Endocrinology and Metabolism|October 30, 2014
Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experienceRamona Dadu, Komal Shah, Naifa L Busaidy, et al.Pageof 31